This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Biochemia Robin S.p.a.. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: The Innovative Contributions of Roberto Assereto
Introduction
Roberto Assereto is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that exhibit antineoplastic activity. His work aims to improve cancer treatment outcomes while minimizing side effects.
Latest Patents
Assereto holds a patent for "Pharmaceutical compositions having antineoplastic activity." This patent describes pharmaceutical compositions that contain unit or separate dosages of 2.5 to 5 grams of reduced glutathione (GSH) along with known anti-tumor agents. These compositions can be used simultaneously, separately, or sequentially in anti-tumor therapy. The compounds developed through this invention have shown surprising results against tumors, effectively avoiding dangerous side effects such as nephrotoxicity induced by cisplatinum, while also increasing long-term survival rates.
Career Highlights
Roberto Assereto is associated with Boehringer Biochemia Robin S.p.a., where he continues to contribute to innovative pharmaceutical research. His work is characterized by a commitment to enhancing cancer therapies and improving patient outcomes.
Collaborations
Assereto has collaborated with notable colleagues, including Michele Tedeschi and Odoardo Tofanetti. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.
Conclusion
Roberto Assereto's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor in the industry. His patented compositions represent a promising advancement in the fight against cancer, aiming to improve patient care and treatment efficacy.